相似文献
1
MRI of nonischemic cardiomyopathy.
AJR Am J Roentgenol. 2010 Oct;195(4):935-40. doi: 10.2214/AJR.10.4222.
2
Advanced Computed Tomography and Magnetic Resonance Imaging in Ischemic and Nonischemic Cardiomyopathies.
Echocardiography. 2025 Feb;42(2):e70106. doi: 10.1111/echo.70106.
3
Role of cardiac MRI in nonischemic cardiomyopathies.
Indian Heart J. 2016 May-Jun;68(3):405-9. doi: 10.1016/j.ihj.2015.09.032. Epub 2016 Jan 18.
4
Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.
Top Magn Reson Imaging. 2008 Feb;19(1):43-57. doi: 10.1097/RMR.0b013e31816fcb22.
5
Role of cardiac MRI in the assessment of nonischemic cardiomyopathies.
Methodist Debakey Cardiovasc J. 2013 Jul-Sep;9(3):149-55. doi: 10.14797/mdcj-9-3-149.
6
A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging.
Radiographics. 2009 Jan-Feb;29(1):89-103. doi: 10.1148/rg.291085052.
7
Cardiac MRI evaluation of nonischemic cardiomyopathies.
J Magn Reson Imaging. 2010 Mar;31(3):518-30; quiz 517. doi: 10.1002/jmri.22030.
8
ACR appropriateness criteria® nonischemic myocardial disease with clinical manifestations (ischemic cardiomyopathy already excluded).
J Thorac Imaging. 2014 Jul;29(4):W44-7. doi: 10.1097/RTI.0000000000000096.
9
Cardiomyopathies (hypertrophy and failure): what can offer cardiac magnetic resonance imaging?
Presse Med. 2011 Sep;40(9 Pt 2):e425-36. doi: 10.1016/j.lpm.2010.12.016. Epub 2011 Jul 26.
10
Role of cardiac magnetic resonance imaging in assessing ischemic and nonischemic cardiomyopathies.
Expert Rev Cardiovasc Ther. 2012 Feb;10(2):223-33. doi: 10.1586/erc.11.194.
引用本文的文献
1
A Cross-talk between Nanomedicines and Cardiac Complications: Comprehensive View.
Curr Pharm Des. 2025;31(10):741-752. doi: 10.2174/0113816128347223241021111914.
2
Pre-test Prediction of Non-ischemic Cardiomyopathies using Time-Series EHR Data.
AMIA Jt Summits Transl Sci Proc. 2024 May 31;2024:239-248. eCollection 2024.
3
Interpretation of pre-morbid cardiac 3T MRI findings in overweight and hypertensive young adults.
PLoS One. 2022 Dec 1;17(12):e0278308. doi: 10.1371/journal.pone.0278308. eCollection 2022.
4
Eosinophilic myocarditis: Case report and brief review of the literature.
Radiol Case Rep. 2022 Nov 9;18(1):306-311. doi: 10.1016/j.radcr.2022.10.036. eCollection 2023 Jan.
5
Cardiac Alterations on 3T MRI in Young Adults With Sedentary Lifestyle-Related Risk Factors.
Front Cardiovasc Med. 2022 Feb 22;9:840790. doi: 10.3389/fcvm.2022.840790. eCollection 2022.
6
Echocardiographic predictors of ventricular arrhythmias in patients with non-ischemic cardiomyopathy.
Int J Cardiol Heart Vasc. 2022 Feb 4;39:100962. doi: 10.1016/j.ijcha.2022.100962. eCollection 2022 Apr.
7
Viewpoints in the diagnosis and treatment of cardiac sarcoidosis: Proposed modification of current guidelines.
Clin Cardiol. 2018 Oct;41(10):1386-1394. doi: 10.1002/clc.23060. Epub 2018 Oct 17.
8
Should Primary Prevention ICDs Still Be Placed in Patients with Non-ischemic Cardiomyopathy? A Review of the Evidence.
Curr Cardiol Rep. 2018 Mar 24;20(5):31. doi: 10.1007/s11886-018-0974-y.
9
A case of cardiac sarcoidosis mimicking cardiac amyloidosis on cardiovascular magnetic resonance.
ESC Heart Fail. 2018 Apr;5(2):306-310. doi: 10.1002/ehf2.12263. Epub 2018 Feb 5.
10
Assessment of myocardial delayed enhancement with cardiac computed tomography in cardiomyopathies: a prospective comparison with delayed enhancement cardiac magnetic resonance imaging.
Int J Cardiovasc Imaging. 2017 Apr;33(4):577-584. doi: 10.1007/s10554-016-1024-8. Epub 2016 Nov 22.
本文引用的文献
1
Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
J Am Coll Cardiol. 2009 Jul 14;54(3):220-8. doi: 10.1016/j.jacc.2009.05.006.
2
Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members.
JACC Cardiovasc Imaging. 2009 Jan;2(1):65-8. doi: 10.1016/j.jcmg.2008.09.008.
3
Axial black blood turbo spin echo imaging of the right ventricle.
Magn Reson Med. 2009 Feb;61(2):307-14. doi: 10.1002/mrm.21864.
4
Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.
Top Magn Reson Imaging. 2008 Feb;19(1):43-57. doi: 10.1097/RMR.0b013e31816fcb22.
5
Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia.
J Cardiovasc Magn Reson. 2008 Jun 20;10(1):32. doi: 10.1186/1532-429X-10-32.
6
MRI in nonischemic acquired heart disease.
J Magn Reson Imaging. 2008 Jun;27(6):1195-213. doi: 10.1002/jmri.21172.
7
Cardiac MR imaging of nonischemic cardiomyopathies.
Magn Reson Imaging Clin N Am. 2008 May;16(2):165-83, vii. doi: 10.1016/j.mric.2008.02.010.
8
The role of cardiovascular magnetic resonance in the diagnosis and management of cardiomyopathies.
J Cardiovasc Med (Hagerstown). 2008 May;9(5):435-49. doi: 10.2459/JCM.0b013e32827ab49f.
9
Cardiovascular magnetic resonance for risk stratification of arrhythmia in hypertrophic cardiomyopathy.
J Am Coll Cardiol. 2008 Apr 8;51(14):1375-6. doi: 10.1016/j.jacc.2008.01.010.
10
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.
J Am Coll Cardiol. 2008 Apr 8;51(14):1369-74. doi: 10.1016/j.jacc.2007.11.071.
Zotero 插件